Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1206-1215
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1206
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1206
Table 2 Clinical features of gastric cancer patients
| Variables | Case, n (%) |
| Age at diagnosis (yr) | |
| < 60 | 113 (31.3) |
| ≥ 60 | 248 (68.7) |
| Gender | |
| Male | 241 (66.8) |
| Female | 120 (33.2) |
| T stage | |
| T1 + T2 | 88 (24.4) |
| T3 + T4 | 273 (75.6) |
| Histologic grade | |
| G1 + G2 | 134 (37.1) |
| G3 + G4 | 227 (62.9) |
| Race | |
| White | 234 (64.8) |
| Asian | 83 (23.0) |
| Black or African American | 12 (3.3) |
| NA | 32 (8.9) |
| Pathologic stage | |
| I | 44 (12.2) |
| II | 117 (32.4) |
| III | 162 (44.9) |
| IV | 30 (8.3) |
| NA | 8 (2.2) |
| Node status | |
| N0 | 111 (30.7) |
| N1-3 | 249 (69.0) |
| NA | 1 (0.3) |
| Metastasis | |
| M0 | 325 (90.0) |
| M1 | 22 (6.1) |
| Mx | 14 (3.9) |
- Citation: Zhang C, Zhang CD, Ma MH, Dai DQ. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. World J Gastroenterol 2018; 24(11): 1206-1215
- URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1206.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1206